These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3015182)

  • 1. Variations in steroid receptors and cyclic AMP binding proteins across human breast cancers: evidence for heterogeneity.
    Senbanjo RO; Miller WR; Hawkins RA
    Br J Cancer; 1986 Jul; 54(1):127-30. PubMed ID: 3015182
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer.
    Watson DM; Hawkins RA; Bundred NJ; Stewart HJ; Miller WR
    Br J Cancer; 1987 Aug; 56(2):141-2. PubMed ID: 2822069
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic AMP binding proteins and prognosis in breast cancer.
    Miller WR; Elton RA; Dixon JM; Chetty U; Watson DM
    Br J Cancer; 1990 Feb; 61(2):263-6. PubMed ID: 2155642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic adenosine-3':5'-monophosphate binding proteins in human mammary tumor cytosol and their relation to estrogen and progesterone receptors. A preliminary study.
    De Bortoli M; Fumero S; Mondino A
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):226-32. PubMed ID: 6860498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of primary neuroendocrine carcinomas of the breast.
    Lopez-Bonet E; Pérez-Martínez MC; Martin-Castillo B; Alonso-Ruano M; Tuca F; Oliveras-Ferraros C; Cufí S; Vazquez-Martin A; Beltràn M; Bernadó L; Menendez JA
    Breast Cancer Res Treat; 2011 Feb; 126(1):241-5. PubMed ID: 20978935
    [No Abstract]   [Full Text] [Related]  

  • 6. Receptor discordance: does it mean anything?
    Johnston SR
    Clin Breast Cancer; 2010 Dec; 10(6):419-20. PubMed ID: 21147684
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclic AMP-binding protein and estrogen receptor: antagonism during nuclear translocation in a hormone-dependent mammary tumor.
    Bodwin JS; Hirayama PH; Cho-Chung YS
    Biochem Biophys Res Commun; 1981 Dec; 103(4):1349-55. PubMed ID: 6277332
    [No Abstract]   [Full Text] [Related]  

  • 8. On the interaction of cyclic AMP-binding protein and estrogen receptor in growth control.
    Cho-Chung YS
    Life Sci; 1979 Apr; 24(14):1231-9. PubMed ID: 224272
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclic AMP binding proteins in human breast cancer.
    Miller WR; Senbanjo RO; Telford J; Watson DM
    Br J Cancer; 1985 Oct; 52(4):531-5. PubMed ID: 2998423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?
    Rhodes A; Jasani B
    J Clin Pathol; 2009 Jan; 62(1):95-6. PubMed ID: 19103868
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic adenosine 3':5'-monophosphate receptor proteins in dysplastic and neoplastic human breast tissue cytosol and their inverse relationship with estrogen receptors.
    Handschin JC; Handloser K; Takahashi A; Eppenberger U
    Cancer Res; 1983 Jun; 43(6):2947-54. PubMed ID: 6303571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of KLF5 in hormonal signaling and breast cancer development.
    Liu R; Dong JT; Chen C
    Vitam Horm; 2013; 93():213-25. PubMed ID: 23810009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of pS2 protein in breast cancer and its relationship with estrogen and progesterone receptors].
    Díez Gibert O; Machuca I; Sebastián MA; Rosel P; Navarro MA
    Med Clin (Barc); 1996 Jun; 107(3):90-2. PubMed ID: 8754494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of malignant breast tumors containing estrogen receptors].
    El'tsina NV
    Vopr Onkol; 1982; 28(4):95-102. PubMed ID: 7046238
    [No Abstract]   [Full Text] [Related]  

  • 15. Estrogen action in human breast cancer (review).
    Edwards DP; McGuire WL
    Anticancer Res; 1982; 2(5):297-308. PubMed ID: 6762142
    [No Abstract]   [Full Text] [Related]  

  • 16. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.
    Bautista S; Vallès H; Walker RL; Anzick S; Zeillinger R; Meltzer P; Theillet C
    Clin Cancer Res; 1998 Dec; 4(12):2925-9. PubMed ID: 9865902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Types of cyclic AMP binding proteins in human breast cancers.
    Miller WR; Hulme MJ; Cho-Chung YS; Elton RA
    Eur J Cancer; 1993; 29A(7):989-91. PubMed ID: 8388698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of pS2 estrogen-inducible protein in primary breast cancer.
    Horiguchi J; Iino Y; Takei H
    Oncology; 1996; 53(1):12-5. PubMed ID: 8570124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid receptors as a guide for therapy of primary and metastatic breast cancer.
    Maass H; Jonat W
    J Steroid Biochem; 1983 Jul; 19(1C):833-7. PubMed ID: 6887903
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue immunoreactive prolactin hormone in breast cancer.
    Castro A; Buschbaum P; Nadji M; Voigt W; Ziegels-Weissman J; Morales A
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):159-70. PubMed ID: 6250206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.